The last selected study was an observational study of 402 hospitalized COVID‐19 pneumonia patients which compared the outcomes (mortality, respiratory failure, IL‐6 level) of patients receiving antidepressants in the course of hospital admission (34 patients: 27 SSRI, 6 SNRI, 1 venlafaxine + duloxetine) versus patients who did not receive any antidepressants (368 patients).33 The gene discussed is IL6; the disease is respiratory failure.